Emergent BioSolutions Inc.EBSNYSE
Loading
Operating cash flow minus capital expenditures
5Y CAGR
-16.9%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $156.80M | +338.0% |
| 2024 | $35.80M | +113.9% |
| 2023 | $-257.90M | -72.0% |
| 2022 | $-149.90M | -256.0% |
| 2021 | $96.10M | -75.7% |
| 2020 | $395.00M | +290.7% |
| 2019 | $101.10M | +433.7% |
| 2018 | $-30.30M | -119.8% |
| 2017 | $153.31M | +773.3% |
| 2016 | $-22.77M | - |